Search by Drug Name or NDC
NDC 00409-4350-03 Diltiazem Hydrochloride 100 mg/1 Details
Diltiazem Hydrochloride 100 mg/1
Diltiazem Hydrochloride is a INTRAVENOUS INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Hospira, Inc.. The primary component is DILTIAZEM HYDROCHLORIDE.
Product Information
| NDC | 00409-4350 |
|---|---|
| Product ID | 0409-4350_18648c0d-5f60-4195-92f0-1dffc1452d4c |
| Associated GPIs | 34000010102140 |
| GCN Sequence Number | 059740 |
| GCN Sequence Number Description | diltiazem HCl VIAL PORT 100 MG INTRAVEN |
| HIC3 | A9A |
| HIC3 Description | CALCIUM CHANNEL BLOCKING AGENTS |
| GCN | 25527 |
| HICL Sequence Number | 000182 |
| HICL Sequence Number Description | DILTIAZEM HCL |
| Brand/Generic | Generic |
| Proprietary Name | Diltiazem Hydrochloride |
| Proprietary Name Suffix | n/a |
| Non-Proprietary Name | DILTIAZEM HYDROCHLORIDE |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Dosage Form | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION |
| Route | INTRAVENOUS |
| Active Ingredient Strength | 100 |
| Active Ingredient Units | mg/1 |
| Substance Name | DILTIAZEM HYDROCHLORIDE |
| Labeler Name | Hospira, Inc. |
| Pharmaceutical Class | Calcium Channel Antagonists [MoA], Calcium Channel Blocker [EPC] |
| DEA Schedule | n/a |
| Marketing Category | ANDA |
| Application Number | ANDA075853 |
| Listing Certified Through | 2024-12-31 |
Package
NDC 00409-4350-03 (00409435003)
| NDC Package Code | 0409-4350-03 |
|---|---|
| Billing NDC | 00409435003 |
| Package | 10 VIAL, PATENT DELIVERY SYSTEM in 1 TRAY (0409-4350-03) / 1 INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION in 1 VIAL, PATENT DELIVERY SYSTEM (0409-4350-13) |
| Marketing Start Date | 2005-04-30 |
| NDC Exclude Flag | N |
| Pricing Information | N/A |